Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, or debt levels. It focuses exclusively on the following share repurchase metrics for the transaction dated May 8, 2025:
- Shares Purchased: 830,504 ordinary shares
- Highest Price Paid: 406.50 pence per share
- Lowest Price Paid: 398.70 pence per share
- Volume Weighted Average Price: 400.99 pence per share
- Post-Transaction Share Capital: 9,017,554,815 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,013,474,610
Material Changes
The primary material change reported is the reduction of outstanding voting shares due to the cancellation of 830,504 shares purchased on May 8, 2025. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclaimer that the announcement does not constitute an offer for securities. The transaction was conducted in accordance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check subsequent filings for updated financial performance metrics not included in this transaction-specific report.